Nivagen Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NIVAGEN PHARMS INC, and what generic and branded alternatives to NIVAGEN PHARMS INC drugs are available?
NIVAGEN PHARMS INC has eight approved drugs.
Drugs and US Patents for Nivagen Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nivagen Pharms Inc | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 213328-003 | Nov 23, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nivagen Pharms Inc | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 213328-005 | Nov 23, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nivagen Pharms Inc | EFINACONAZOLE | efinaconazole | SOLUTION;TOPICAL | 211969-001 | Jun 21, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nivagen Pharms Inc | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 213328-002 | Nov 23, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nivagen Pharms Inc | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 212627-002 | Nov 3, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nivagen Pharms Inc | SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 216042-001 | Feb 27, 2024 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.